University Surgery Clinic, Pirogov Russian National Research Medical University, Moscow, Russia.
Phlebology. 2021 Jul;36(6):450-455. doi: 10.1177/0268355520975582. Epub 2020 Dec 13.
The aim of the study was to assess the inferior vena cava filter (IVCF) utilization in patients with venous thromboembolism (VTE) in tertiary care.
We performed a retrospective analysis of database of a tertiary hospital in 2016-2017. All the records of patients admitted for VTE or diagnosed with VTE being hospitalized for other reasons were extracted. The data collected were number of patients, who received IVCF, indications to filter insertion, PE and death rate after procedure, frequency of IVCF occlusion.
2399 patients with VTE were admitted to hospital. 442 (18,4%) of them received IVCF (239 in 2016 and 203 in 2017). Retrievable models were used in most cases (98,8%). In 119 (5,0%) patients cava filters were used due to contraindications for anticoagulation, while in 184 (7,7%) patients' anticoagulation was not effective and thrombosis progression was registered. 101 (4,2%) patients received IVCF due to high PE risk (length of floating thrombus ≥7 cm, in proximal location), high pulmonary hypertension was indication to IVCF insertion in 38 (1,6%) patients with deep vein thrombosis (DVT) in combination with pulmonary embolism (PE). Overall mortality rate after IVCF insertion was 5 (0,2%). No fatal PE was registered. IVCF occlusion during hospitalization occurred in 116 (4,8%) cases. Only 29 (1,2%) of patients were admitted back for IVCF removal.
Every one in five patients with proximal DVT and/or PE receives IVCF in a routine practice in tertiary hospital. The most common indications for IVCF implantation were inability for anticoagulation or anticoagulation failure. Removal rate of retrievable cava filters is low.
本研究旨在评估三级护理中静脉血栓栓塞症(VTE)患者下腔静脉滤器(IVCF)的使用情况。
我们对 2016 年至 2017 年三级医院的数据库进行了回顾性分析。提取所有因 VTE 住院或因其他原因住院诊断为 VTE 的患者记录。收集的数据包括接受 IVCF 的患者人数、滤器置入的指征、PE 和术后死亡率、IVCF 闭塞的频率。
2399 例 VTE 患者住院。其中 442 例(18.4%)接受了 IVCF(2016 年 239 例,2017 年 203 例)。大多数情况下使用可回收模型(98.8%)。在 119 例(5.0%)患者中,由于抗凝禁忌而使用腔静脉滤器,而在 184 例(7.7%)患者中,抗凝无效且有血栓进展记录。101 例(4.2%)患者因高 PE 风险(漂浮血栓长度≥7cm,位于近端)接受 IVCF,38 例(1.6%)DVT 合并 PE 患者因高肺动脉高压而接受 IVCF 置入。IVCF 置入后总死亡率为 5(0.2%)。未发生致命性 PE。住院期间 IVCF 闭塞发生率为 116(4.8%)。仅 29 例(1.2%)患者因 IVCF 取出而再次入院。
在三级医院的常规实践中,每 5 例近端 DVT 和/或 PE 患者中就有 1 例接受 IVCF。IVCF 植入的最常见指征是无法抗凝或抗凝失败。可回收腔静脉滤器的取出率较低。